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ABSTRACT
Diabetes mellitus is a metabolic disorder indicated by hyperglycaemia due to lack of insulin production,
insulin activity, or both. It causes oxidative stress that may damage the receptor of Growth Hormone Releasing
Hormone (GHRH) in the pituitary. As the result, Growth Hormone (GH) and Insulin-like Growth Factor-1 (IGF-
1) production are decreased and glucose uptakes to the cell is inhibited. Aloe vera has a high antioxidant
activity. It is possible to counter oxidative stress in unregulated the production of IGF-1. This study aimed to
determine the effect of A. vera extracts to the level of IGF-1 from visceral fat tissue Rattus norvegicus wistar
diabetes mellitus. This study used 24 R. norvegicus wistar male. R. norvegicus STZ-induced diabetes mellitus
R. norvegicus were grouped into positive control (C+), 30 mg/day, 60 mg/day, 120 mg/day.  Fasting blood
glucose test was performed to determine the successful induction of diabetes mellitus (DM) three days after
induced.  Non-DM rats (NDM) were grouped into negative control (C-), 30 mg/day, 60 mg/day, and 120 mg/
day. Each group was consisting of three replications. Each animal, except the controls, were treated 3 ml
suspension of A. vera extract for 14 days by gavage. IGF-1 levels were measured using indirect ELISA. The
result showed  that the extract of A. vera significantly influenced the IGF-1 levels in DM group.  The dose of
60 and 120 mg/day significantly raised the level of IGF-1 compared to C+. In NDM group the dose of 60 mg/
day significantly raised the level of IGF-1 compared to C-.
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INTRODUCTION
Diabetes mellitus is a chronic disease and known as Non-Communicable Diseases
(NCD) which commonly occurs in various regions of the world. Death due to NCDs globally
increased by 15% from 2010 to 2020. The largest increased about 20%, was observed in
African region, East Mediterania, and Southeast Asia (WHO, 2010). WHO reported that the
incidence of diabetes mellitus by 364 million people around the world. Based on the final
diagnosis, a total sample of 24,417 from Indonesia’s population aged over 15 years had
shown that as many as 10.2% were having diabetes mellitus and 5,3% at a young age (age
15-24 years). There are two types of diabetes mellitus, diabetes mellitus type 1 is characterized
by insulin deficiency and diabetes mellitus type 2 is due ineffective function of insulin. A
person suffering from diabetes mellitus characterized by the level of  fasting plasma glucose
(FPG) of 125 mg/dl which equal to 200 mg/dl two hours after eating. Long-term chronic
hyperglycaemia can lead to various organs complications, such as blindness, kidney failure,
ulcers, sexual dysfunction, cardiovascular disease, and liver disorders (WHO, 2011a; WHO,
2011b).
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Hyperglycaemia causes oxidative stress which produces more free radicals than anti-
oxidants in the body. Oxidative stress may cause damage to the Growth Hormone Releas-
ing Hormone (GHRH) receptor in pituitary which affects the secretion of Growth Hormone
(GH) and reduced the production of Insulin-like Growth Factor-1 (IGF-1). When production of
IGF-1 is low, so does the formation of receptor glucose and it will aggravate the condition of
hyperglycaemia because the glucose that enters the cell is low and the energy needed will
be slightly gained. In order to fulfill the energy requirement, body will acquire it from fat. Fat
molecules are broken down into fatty acids and caused  ketoacidosis due to the rising of
acid levels in blood (Forbes et al., 2008; Bedard et al., 2008; Riddell & Perkins, 2006).
In order to return the production of IGF-1 to normal, the GHRH receptor damage must be
minimized by reducing the oxidative stress. The stress condition can be improved if the
production of free radicals and antioxidants are well-balanced. Antioxidant are substances
that can scavange the oxidized substrate and inhibit the oxidation of certain substrates (Hlliwell
& Gutteridge In : Droge, 2002). There are many different kinds of plants contains high anti-
oxidant, such as Aloe vera which is commonly used as a remedy for various diseases and
can be used as astringent, hemostatic, antiseptic, antibacterial, anti-inflammatory, antican-
cer, and antidiabetic (Rajasekaran et al., 2006; Afaf et al,. 2008; Joseph & Raj, 2010).
Aloe vera extract can lower glucose levels in diabetic rats and rabbit blood. The de-
creasing glucose level indicates that the extract A. vera stimulates insulin secretion and the
regeneration of pancreatic β-cells (Saif-Ur-Rehman et al., 2011; Sujono & Wahyu, 2005;
Solomon et al. within Yeggnisetty et al., 2012). Aloe vera contains about 200 different sub-
stances benefits for human health including vitamins, enzymes, minerals, amino acids, and
antioxidant (Joseph & Raj, 2010). Natural antioxidants that are found in leaf gel of A. vera are
vitamin A, vitamin C, vitamin E (Miladi & Damak, 2008). Thus, A. Vera might be a potential




A total of 24 male of R. norvegicus Wistar (150-200 g) were divided into 12 nondiabetic
mellitus (NDM) and 12 streptozotocin (STZ)-induced diabetic mellitus (DM) by 60 mg/Kg
BW via intraperitoneal injection. Three days later, the fasting blood glucose test was per-
formed to determine the successful induction of diabetes mellitus. NDM group were divided
into negative control (C-), NDM1 (30 mg/day), NDM2 (60 mg/day), NDM3 (120 mg/day). DM
group was divided into positve control (C+), DM1 (30 mg/day), DM2 (60 mg/day), DM3 (120
mg/day). Each group consisted of three replicate. In each group except the control were
given 3 ml suspension of extract A. vera with doses of 30, 60, and 120 mg/day by gavage for
14 days.
Aloe vera Extract Preparations
Leaves of healthy A. vera obtained in the area of Malang/Batu were cleaned using cal-
cium hipoclorite and distilled water. After no mucous left, the leaves were cut on the base
about 1 cm and the flesh was taken. The flesh was rinsed under the running tap water then
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cut into small pieces and blended. After that, the gel soaked using ethanol 96% (1:4 v:v) and
stirred for 10 h at 30°C, allowed for precipitation for 10 h at 10°C. The sediment was sepa-
rated from the solution by filtration and dried with vacuum dryer at 50°C (Padmadisastra et
al., 2003; Kusumawati & Pratiwi, 2009).
Determination of IGF-1 Level in Visceral Fat Tissue
Two weeks after the treatment, all of the R. norvegicus were decapitated and the vis-
ceral fat tissue was taken. A total of 50 mg tissue were grinded and added with 500 µl
Radioimmuno Precipitation Assay (RIPA) buffer lysis. The suspensions were then vortexed
and incubted at 4°C for 30 mins. After 30 mins incubation, the fat tissue suspensions were
centrifuged at 12,000 rpm for 20 mins. The supernatant was taken and moved to a new
microtube to measure the IGF-1 level using ELISA reader at 492 nm (Titer Assay Enzyme
Design EIA Kit, Catalog No. 900-101).
Statistical Analysis
The data was in the form of absorbance values and determination of the IGF-1 level
measurement   used standard curve y = 0.0003x + 0.0008. The statistic analysis was per-
formed using One way ANOVA (p<0.05) and followed by LSD.
RESULT AND DISCUSSION
The result of IGF-1 measurements on visceral fat tissue of R. norvegicus showed that
the extract of A. vera increased the levels of IGF-1 (Figure 1). ANOVA test was able to show
that the treatment using A. vera extract was significantly affect IGF-1 levels (p<0.05). LSD
test showed that the levels of IGF-1 on visceral fat tissue R. norvegicus diabetes mellitus
which were treated with 60 mg/day and 120 mg/day were significantly different compared to
the positive control (C+) and 30 mg/day on R. norvegicus DM group whereas in NDM group
there was showed that 60 mg/day A. vera extract treatment was significantly different com-
pared to negative control (C-), but not significantly different compared to 30 mg/day and 120
mg/day dosage.
Streptozotocin is a compound that can cause a quick damage to pancreatic beta cells
so that insulin production is reduced (Pi et al., 2007) and based on the data STZ administra-
tion was succesfully induced diabetes mellitus. Decreased insulin production can lead to
hyperglycemia. Hyperglycemia causes oxidative stress conditions and may cause damage
Figure 1. IGF-1 Levels on DM and NDM Rattus norvegicus Visceral Fats Tissue. Data present
the mean of three replicates and the standard error.
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in the pituitary GHRH receptors that results in the decreased secretion of GH. When GH
secretion decreases, so does the IGF-1 production in the liver (Forbes et al., 2008; Bedard
et al., 2008). The extract given to R. norvegicus DM was able to increase the levels of IGF-
1. Perhaps, it was possible because A. vera has a high antioxidant activity which reduces
the concentration of free radicals by 50% and can inhibit the release of ROS from phorbol
12-myristate 13-acetate (PMA). The other content is enzyme SOD which is thought that the
increased production of SOD leads to cell protecting mechanism against free radical expo-
sure (Hart et al., 1990; Hamman, 2008; Khaing, 2011; Erejuwa et al., 2011).
The presence of antioxidants can reduce oxidative stress so that the pituitary GHRH
receptor synthesis can be returned to normal and the production of GH and IGF-1 will be
improved. The other mechanism that can improve the production of IGF-1 comes from polysac-
charides Acemannan which acts as an antioxidant and expected to repair damaged pancre-
atic β cells (Chun-hui In : Cock, 2011; Hamman, 2008). In this study the extraction process
was using  ethanol 96% as precipitant which will generate a lot of acemannan polysaccha-
rides according to Kusmawati & Pratiwi (2009).
The mechanism of β-cell repairing is analogous to glucomannan polysaccharides that
can increase the mRNA gene of proinsulin levels in rats with diabetes mellitus. An increase
in mRNA level is characterized by an increase in the number of β-cells and so does the the
production of insulin (Fatchiyah, 2011). Increased insulin production can improve the condi-
tions of hyperglycemia and pressing the oxidative stress. The oxidative stress can be re-
duced if the production of IGF-1 can be returned to normal. The biological activity can occur
not only one compound that works, but a whole compounds contained in A. vera extract that
work synergistically (Dagne et al., In: Hamman, 2008)
Based on the result, A. vera can be used as a candidate to treat diabetes mellitus due to
the increased levels of IGF-1 and the hyperglycemia seems to be inhibited as well so that the
danger of cell damage caused by oxidative stress can be avoided. In addition, the glucose
is able to enter the cells and can be used as energy and the use of fat catabolism can be
minimized so that ketoacidosis can be avoided. The dose extract of 30 mg/day didn’t sig-
nificantly affect the levels of IGF-1 on R. norvegicus normal compared to C- treatment, but
the dose of 60 mg/day was significant. In both DM and NDM groups, the levels of IGF-1 on R.
norvegicus given with 120 mg/day were lower than treated rats with 60 mg/day. It is possible
that the highest dose (20 mg/day) has been overeffective so that it can disrupt the physiology
of the body. Mali et al. (2011) mentioned that A. vera overdose can result in side effects such
as lack of electrolytes, fluid imbalance, and intestinal cramps. Therefore the provision of A.
vera as much as 120 mg/day are not recommended.
CONCLUSION
The extract of A. vera significantly increased the IGF-1 levels on R. norvegicus visceral
fat tissue DM via oral administration with dose 60 mg/day and 120 mg/day compared to C+
whereas on normal R. norvegicus visceral fat tissue, the extract of A. vera seemed to in-
crease the IGF-1 levels in dose 60 mg/day compared to C-. Thus, dose of 60 mg/day A. vera
extract is suggested to be an alternative dose treatment for DM.
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